Sareum’s small molecule drug discovery expertise builds value by developing drug candidates, focused on cancer and autoimmune disease, for licencing to pharmaceutical and biotechnology companies.
Find out more about us
20 November 2017
14 November 2017
31 October 2017
19 October 2017
Find out more
Sareum actively seeks collaboration partners for its research programmes.
Sareum has an innovative pipeline of drug development candidates.
Biotech Capital, Feb 2017 (Video)
Share price data
Regulatory News Service (RNS)
Sareum LimitedUnit 2A, Langford ArchLondon Road, PampisfordCambridge CB22 3FXUnited Kingdom
tel: +44 (0) 1223 497700fax: +44 (0) 1223 497701
FY Results 2017 (0.9 MB)
Notice of AGM 2017 (1.5MB)
Annual report PDF 2017 (2.3MB)